LA-419
LA-419 is an orally active nitric oxide (NO) donor. LA-419 can significantly reduce the amount of fecal worm eggs excreted, shorten the duration of egg excretion, and also decrease the number of larvae in the lungs and the number of parasitic females in the intestines in mice infected with S. venezuelensis. LA-419 can reduce the formation of atherosclerosis in apolipoprotein E-deficient mice. LA-419 can be used for the researches of infection and cardiovascular disease[1].
Product Specifications
CAS Number
263754-93-4
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
NO Synthase
Related Pathways
Immunology/Inflammation
Field of Research
Infection; Cardiovascular Disease
Smiles
[H][C@]12[C@]([C@@H](SC(C)=O)CO2)([H])OC[C@H]1O[N+]([O-])=O
Molecular Formula
C8H11NO6S
Molecular Weight
249.24
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
KRT6B, ID (KRT6B, K6B, KRTL1, Keratin, type II cytoskeletal 6B, Cytokeratin-6B, Keratin-6B, Type-II keratin Kb10) (FITC) discontinued
